These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 26434872)
1. Transducer-like Enhancer of Split 1 as a Novel Immuno- histochemical Marker for Diagnosis of Synovial Sarcoma. Atef A; Alrashidy M Asian Pac J Cancer Prev; 2015; 16(15):6545-8. PubMed ID: 26434872 [TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma. Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272 [TBL] [Abstract][Full Text] [Related]
4. Transducer-like enhancer of split 1 (TLE1) expression as a diagnostic immunohistochemical marker for synovial sarcoma and its association with morphological features. Bakrin IH; Hussain FA; Tuan Sharif SE Malays J Pathol; 2016 Aug; 38(2):117-22. PubMed ID: 27568668 [TBL] [Abstract][Full Text] [Related]
5. Tissue microarray based immunohistochemical study of TLE1 in synovial sarcoma and its histologic mimics. Sivakoti S; Uppin SG; Uppin MS; Tara RP; Prayaga AK; Challa S Indian J Pathol Microbiol; 2021; 64(2):310-315. PubMed ID: 33851625 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical validation of TLE1, a novel marker, for synovial sarcomas. Rekhi B; Basak R; Desai SB; Jambhekar NA Indian J Med Res; 2012 Nov; 136(5):766-75. PubMed ID: 23287123 [TBL] [Abstract][Full Text] [Related]
7. Specificity of TLE1 expression in unclassified high-grade sarcomas for the diagnosis of synovial sarcoma. Valente AL; Tull J; Zhang S Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):408-13. PubMed ID: 23197007 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas. Yoshikawa H; Rettig WJ; Lane JM; Takaoka K; Alderman E; Rup B; Rosen V; Healey JH; Huvos AG; Garin-Chesa P Cancer; 1994 Aug; 74(3):842-7. PubMed ID: 8039112 [TBL] [Abstract][Full Text] [Related]
9. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms. Kosemehmetoglu K; Vrana JA; Folpe AL Mod Pathol; 2009 Jul; 22(7):872-8. PubMed ID: 19363472 [TBL] [Abstract][Full Text] [Related]
10. Expression of TLE1 in Malignant Melanoma With Spindle Cell Morphology: A Potential Diagnostic Pitfall. Morrell TJ; Xiong Y; Deng A; Dresser K; O'Donnell P; Cornejo KM Int J Surg Pathol; 2019 May; 27(3):259-262. PubMed ID: 30301396 [TBL] [Abstract][Full Text] [Related]
11. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases. Knösel T; Heretsch S; Altendorf-Hofmann A; Richter P; Katenkamp K; Katenkamp D; Berndt A; Petersen I Eur J Cancer; 2010 Apr; 46(6):1170-6. PubMed ID: 20189377 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of SOX10 to distinguish malignant peripheral nerve sheath tumor from synovial sarcoma, including intraneural synovial sarcoma. Kang Y; Pekmezci M; Folpe AL; Ersen A; Horvai AE Mod Pathol; 2014 Jan; 27(1):55-61. PubMed ID: 23929265 [TBL] [Abstract][Full Text] [Related]
13. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Terry J; Saito T; Subramanian S; Ruttan C; Antonescu CR; Goldblum JR; Downs-Kelly E; Corless CL; Rubin BP; van de Rijn M; Ladanyi M; Nielsen TO Am J Surg Pathol; 2007 Feb; 31(2):240-6. PubMed ID: 17255769 [TBL] [Abstract][Full Text] [Related]
14. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study. Ito J; Asano N; Kawai A; Yoshida A Hum Pathol; 2016 Jan; 47(1):32-7. PubMed ID: 26520417 [TBL] [Abstract][Full Text] [Related]
15. Fine-needle aspiration biopsy of synovial sarcoma. A cytomorphologic analysis of primary, recurrent, and metastatic tumors. Kilpatrick SE; Teot LA; Stanley MW; Ward WG; Savage PD; Geisinger KR Am J Clin Pathol; 1996 Dec; 106(6):769-75. PubMed ID: 8980353 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of cytokeratin subsets for distinguishing monophasic synovial sarcoma from malignant peripheral nerve sheath tumor. Smith TA; Machen SK; Fisher C; Goldblum JR Am J Clin Pathol; 1999 Nov; 112(5):641-8. PubMed ID: 10549251 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Utility of TLE1 (Transducer-Like Enhancer of Split 1) in Distinguishing Synovial Sarcoma from Mimicking Tumors. Qureshi MB; Tariq MU; Abdul-Ghafar J; Chundriger Q; Ud Din N Int J Gen Med; 2021; 14():9173-9179. PubMed ID: 34880656 [TBL] [Abstract][Full Text] [Related]
18. Transducer-like enhancer of split 1 (TLE1) as a novel biomarker for diagnosis of synovial sarcoma correlates with translocation t(X;18): a study of 155 cases in China. Li Y; Zhang X; Wang A; Ding S; Li Y; Wang H; Lv Y; Shi H Int J Clin Exp Pathol; 2019; 12(1):251-258. PubMed ID: 31933740 [TBL] [Abstract][Full Text] [Related]
19. Immunostaining for SYT protein discriminates synovial sarcoma from other soft tissue tumors: analysis of 146 cases. He R; Patel RM; Alkan S; Hammadeh R; Weiss SW; Goldblum JR; Venkataraman G; Baila H Mod Pathol; 2007 May; 20(5):522-8. PubMed ID: 17334346 [TBL] [Abstract][Full Text] [Related]
20. Aspiration cytology of biphasic and monophasic synovial sarcoma. A report of two cases. Aisner SC; Seidman JD; Burke KC; Young JW Acta Cytol; 1993; 37(3):413-7. PubMed ID: 7684548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]